- 03-05-2012Bosnia & Herzegovina to Join EGA
- 01-05-2012FDA Approved Elelyso (taliglucerase Alfa)
- 19-04-2012Macedonia and Switzerland to Join EGA
- 26-03-2012Humanitarian Aid (March 2012)
- 22-02-2012Shire Announces European Approval of Manufacturing Facility For VPRIV
spacer
All our 34 members are not for profit organisations which are under the control of patient representatives with the aim to provide support and information to gaucher patients as well as to their relatives. Click on the map above to get the link to a member country for local support, advice and news.
Gaucher Disease is an autosomal recessive disease and the most common Lysosomal Storage Disorder. It is caused by deficiency of a specific enzyme in the body, caused by a genetic mutation received from both parents.
The EGA is encouraging and promoting scientific and medical research into Gaucher disease.
The European Working Group on Gaucher Disease (EWGGD) is bringing together scientists and clinicians who have an interest in and experience of studying and treating Gaucher patients.
